Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease: Is the Difference Real?

Tamara Mogilevski, Miles P. Sparrow

Research output: Contribution to journalEditorialOtherpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1094-1096
Number of pages3
JournalDigestive Diseases and Sciences
Volume63
Issue number5
DOIs
Publication statusPublished - May 2018

Cite this